Home Behandelprotocollen MDS-MPN-u Richtlijnen en literatuur

Richtlijnen

Er is op dit moment geen behandelrichtlijn voor MDS/MPN-u.

Literatuur

  1. Palomo L et al. Molecular landscape and clonal architecture of adult myelodysplastic/ myeloproliferative neoplasms. Blood 2020; 136(16):1851-62
  2. Arber DA et al. The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia. Blood 2016; 127(20):2391-405
  3. DiNardo CD et al. Myelodysplastic/myeloproliferative neoplasms, unclassifiable (MDS/MPN-u): natural history and clinical outcome by treatment strategy. Leukemia. 2014; 28(4):958-61
  4. Mughal TI et al. An International MDS/MPN working group's perspective and recommendations on molecular pathogenesis, diagnosis and clinical characterization of myelodysplastic/ myeloproliferative neoplasms. Haematologica 2015; 100(9):1117-30
  5. Savona MR et al. An international consortium proposal of uniform response criteria for myelodysplastic/ myeloproliferative neoplasms (MDS/MPN) in adults. Blood 2015; 125(12):1857-65
  6. Mangaonkar AA et al. Clinicopathologic characteristics, prognostication and treatment outcomes for myelodysplastic/ myeloproliferative neoplasm, unclassifiable (MDS/MPN-u): Mayo Clinic-Moffitt Cancer Center study of 135 consecutive patients. Leukemia 2020; 34(2):656-61

 

Ga terug naar de MDS/MPN-u homepage of lees meer over MDS/MPN-u:

Ga terug naar de algemene homepage Behandelprotocollen.